ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome

This study has been completed.
Study NCT00001123.   Last updated on November 11, 2005.   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001123


Locations
United States, Alabama
NIAID/DMID/CASG Central Unit    
      Birmingham, Alabama, United States, 35294

Sponsors and Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers